| Go Pro | AZ1 Chatter | IMYO FYI | Tell your friends and family about NICHEY & AZ1 |

Elucid, a company developing a novel, non-invasive medical software to comprehensively characterize cardiovascular disease, announced the closing of a $27 Million Series B financing round.  The round was led by an undisclosed strategic investor, with